Ali Alsanousi

498 total citations · 1 hit paper
5 papers, 340 citations indexed

About

Ali Alsanousi is a scholar working on Pathology and Forensic Medicine, Neurology and Rheumatology. According to data from OpenAlex, Ali Alsanousi has authored 5 papers receiving a total of 340 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Pathology and Forensic Medicine, 2 papers in Neurology and 1 paper in Rheumatology. Recurrent topics in Ali Alsanousi's work include Multiple Sclerosis Research Studies (2 papers), Peripheral Neuropathies and Disorders (2 papers) and Rheumatoid Arthritis Research and Therapies (1 paper). Ali Alsanousi is often cited by papers focused on Multiple Sclerosis Research Studies (2 papers), Peripheral Neuropathies and Disorders (2 papers) and Rheumatoid Arthritis Research and Therapies (1 paper). Ali Alsanousi collaborates with scholars based in United Kingdom, Saudi Arabia and Spain. Ali Alsanousi's co-authors include Richard Nicholas, Jeremy Chataway, Virginia L. Calder, Casper Nielsen, Nadine Schuerer, John Greenwood, K.R. Hunter, Jennifer M. Nicholas, Nick C. Fox and Valerie Anderson and has published in prestigious journals such as The Lancet, Neurology and Muscle & Nerve.

In The Last Decade

Ali Alsanousi

4 papers receiving 332 citations

Hit Papers

Effect of high-dose simvastatin on brain atrophy and disa... 2014 2026 2018 2022 2014 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ali Alsanousi United Kingdom 4 217 89 80 62 50 5 340
Shaul Kadosh United States 6 333 1.5× 111 1.2× 191 2.4× 46 0.7× 31 0.6× 11 430
Hongshan Ma China 9 149 0.7× 59 0.7× 145 1.8× 62 1.0× 43 0.9× 13 317
Christopher LaGanke United States 9 193 0.9× 65 0.7× 80 1.0× 44 0.7× 24 0.5× 28 287
Ali Maisam Afzali Germany 9 93 0.4× 36 0.4× 31 0.4× 120 1.9× 59 1.2× 16 359
Raffaele Murru Italy 11 183 0.8× 77 0.9× 29 0.4× 83 1.3× 20 0.4× 23 368
Gaetano Desina Italy 8 107 0.5× 29 0.3× 37 0.5× 213 3.4× 48 1.0× 10 502
Zhi Qu United States 7 74 0.3× 28 0.3× 31 0.4× 95 1.5× 95 1.9× 9 301
Dallas Boodhoo United States 11 68 0.3× 25 0.3× 31 0.4× 154 2.5× 69 1.4× 21 395
Yusuke Terada Japan 7 277 1.3× 73 0.8× 241 3.0× 44 0.7× 31 0.6× 16 417
Nancy McLinskey United States 4 326 1.5× 108 1.2× 283 3.5× 44 0.7× 32 0.6× 4 405

Countries citing papers authored by Ali Alsanousi

Since Specialization
Citations

This map shows the geographic impact of Ali Alsanousi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali Alsanousi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali Alsanousi more than expected).

Fields of papers citing papers by Ali Alsanousi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ali Alsanousi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali Alsanousi. The network helps show where Ali Alsanousi may publish in the future.

Co-authorship network of co-authors of Ali Alsanousi

This figure shows the co-authorship network connecting the top 25 collaborators of Ali Alsanousi. A scholar is included among the top collaborators of Ali Alsanousi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ali Alsanousi. Ali Alsanousi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

5 of 5 papers shown
1.
Alsanousi, Ali, et al.. (2025). Effect of early activation and perimodiolar electrodes on cochlear implant impedance. European Archives of Oto-Rhino-Laryngology. 283(3). 1597–1609.
2.
Chataway, Jeremy, Nadine Schuerer, Ali Alsanousi, et al.. (2014). Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trial. The Lancet. 383(9936). 2213–2221. 304 indexed citations breakdown →
3.
Chataway, Jeremy, Nadine Schuerer, Ali Alsanousi, et al.. (2013). THE MS-STAT TRIAL: High Dose Simvastatin Slows Brain Atrophy and Delays Disability in Secondary Progressive Multiple Sclerosis: A Phase II Placebo-Controlled Trial (PL02.001). Neurology. 80(7_supplement). 6 indexed citations
4.
Márquez‐Infante, Celedonio, Sinéad M. Murphy, Ali Alsanousi, et al.. (2013). Asymmetric sensory ganglionopathy: A case series. Muscle & Nerve. 48(1). 145–150. 5 indexed citations
5.
Nicholas, Richard, et al.. (2011). Development of oral immunomodulatory agents in the management of multiple sclerosis. Drug Design Development and Therapy. 5. 255–255. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026